Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.
Sokolowska O, Rodziewicz-Lurzynska A, Pilch Z, Kedzierska H, Chlebowska-Tuz J, Sosnowska A, Szumera-Cieckiewicz A, Sokol K, Barankiewicz J, Salomon-Perzynski A, Ciepiela O, Lech-Maranda E, Golab J, Nowis D.
Sokolowska O, et al. Among authors: sokol k.
Clin Exp Med. 2023 Sep;23(5):1563-1572. doi: 10.1007/s10238-022-00878-1. Epub 2022 Aug 31.
Clin Exp Med. 2023.
PMID: 36044158
Free PMC article.